News
Spironolactone does not reduce the rate of cardiovascular death or heart failure in patients undergoing maintenance dialysis.
Three decades after her first pimple, one writer has spent thousands of pounds in the pursuit of clear skin. What worked?
15d
MedPage Today on MSNSpironolactone Fails to Cut Serious Cardiac Events in End-Stage Kidney DiseaseDaily treatment with a mineralocorticoid receptor antagonist flopped for reducing serious cardiac events in kidney failure ...
Sometimes the acne breakout may be the body's way of asking for help. Hormonal acne is one type that shows health problems beyond just skin issues.
PCOS-related acne falls under the hormonal acne umbrella. While this term isn’t an official medical diagnosis, dermatologists ...
4d
Allure on MSNTwo Black Women Get Candid About Their Experiences on AccutaneA full review of what it was like for two patients with darker skin to take isotretinoin—and what happened after they went ...
During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...
Teen Vogue turned to board-certified dermatologists to learn all about acne, one of the most common symptoms of “second ...
Taking multiple blood pressure medications but still have high readings? Aldosterone excess might be sabotaging your ...
Mortality Risk Among Patients on Dialysis Is Not Reduced With Steroidal MRAs, Meta-analysis Suggests
Steroidal mineralocorticoid receptor antagonists (MRAs) may not lower risk for all-cause or cardiovascular (CV) mortality among patients receiving maintenance dialysis, according to a meta-analysis ...
TRAFFIC CRASH: At 8:43 p.m. May 2, a deputy responded to 19 Mile Road and 30 th Avenue after a caller reported a vehicle in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results